BOLD Boundless Bio, Inc. Common Stock PHARMACEUTICAL PREPARATIONS Best Pharmaceutical Stocks 2026 →

Boundless Bio (BOLD) Stock: Buy, Sell, or Hold?

$2.32
-0.06 (-2.52%) ▼
5d: -7.2% 30d: -4.92% 90d: -21.62%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (58%)
Quality Score
33/100
Position
OVERSOLD
30-Day Fair Range
$2.37 – $2.47
Position: OVERSOLD
Forward P/E & Valuation
-3.1x
Next 12M consensus est.
Wall Street Target
$4.00
+72.4% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$2.28 / $2.54
Trend: Downtrend
💡Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: BOLD shows conflicting indicators. Wait for confirmation before entering.

Get Alerted When BOLD Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

In-depth Analysis How we analyze

Valuation Analysis: BOLD is currently trading at $2.32, which is considered oversold relative to its 30-day fair value range of $2.37 to $2.47.

Technical Outlook: Technically, BOLD is in a downtrend. The price is currently testing key support at $2.28. A bounce from this level would confirm strength, while a break below could signal further downside.

Market Sentiment: BOLD scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $4.00 (+72.4%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position OVERSOLD
Historical Trading Range $2.37 - $2.47
Company Quality Score 33/100 (SELL)
Volume Confirmation HIGH
Confidence Score 57.9%

Trading Range & Key Levels

30-Day Trading Range $2.37 - $2.47
Current vs Trading Range OVERSOLD
Support Level $2.28
Resistance Level $2.54
Current Trend Downtrend
Technical data as of Nov 20, 2026

Institutional Signals, 13F Whale Activity & Setup Structure

Quantitative Research Feed
30D Insider Cluster Signal NET BUYING
30D Insider Buyers: 1 insiders ($389,581)
30D Net Insider Flow: +$389,581

Quantitative Signal Breakdown

  • BULLISH: Price oversold vs 30-day range
  • BEARISH: Weak technical setup (25/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 72.4% below Wall St target ($4.00)
  • WARNING: Composite score 33/100 in the bottom quintile — this cohort historically lags the market

Fundamental Context

Forward P/E (Next Year Est.) -3.09
Wall Street Target $4.00 (+72.4%)
Share BOLD Analysis

Share this live BOLD analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (BOLD)

Bullish 2 Retail Mentions
Reddit / WSB Comments
1
Bearish
Retail Stream Volume
1 msgs
24h retail stream
Last Tracked
Sep 21, 2026
Daily AI digest
AI Retail Discussion Summary: Bullish sentiment dominates $BOLD on StockTwits with no new articles on Yahoo Finance.
Aggregated from r/wallstreetbets, r/stocks & retail trader streams. View All Trending Reddit & WSB Stocks →
Last updated: November 22, 2026 6:09 AM ET
Data refreshes hourly during market hours. Next update: 7:09 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for BOLD.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
CYTK
Cytokinetics Inc
STRONG BUY
22 analysts
$109 71 BUY
INSM
Insmed Inc
STRONG BUY
24 analysts
$194 39 SELL
MDGL
Madrigal Pharmaceuticals…
STRONG BUY
19 analysts
$689 42 HOLD
CRNX
Crinetics Pharmaceutical…
STRONG BUY
17 analysts
$86 46 HOLD
CRSP
Crispr Therapeutics AG
BUY
23 analysts
$85 52 HOLD
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals